Systematic intensive therapy in addition to continuous glucose monitoring in adults with type 1 diabetes: a multicentre, open-label, randomised controlled trial
The study was supported by the Swedish state, Region Västra Götaland, and the Swedish Diabetes Foundation.
Authors
- Arndís F. Ólafsdóttir (ORCID: https://orcid.org/0000-0002-2083-2512)
- Per-Henrik Nilsson
- Marcus Lind (ORCID: https://orcid.org/0000-0002-3796-9283)
- Kari Anne Sveen (ORCID: https://orcid.org/0000-0002-1034-9965)
- Henrik Imberg (ORCID: https://orcid.org/0000-0001-9447-663X)
- Sofia Sterner Isaksson (ORCID: https://orcid.org/0000-0002-1302-3629)
- Helene Holmer (ORCID: https://orcid.org/0000-0003-0464-6485)
- Sara Hallström (ORCID: https://orcid.org/0000-0002-1119-5267)
- Magnus Wijkman (ORCID: https://orcid.org/0000-0002-4757-9051)
- Marie Ekström
Institutions
- Linköping University (SE)
- Oslo University Hospital (NO)
- Sahlgrenska University Hospital (SE)
- NU Hospital Group (SE)
- Kemakta Konsult (SE)
- Centralsjukhuset Kristianstad (SE)
- Växjö Kommun (SE)
- Statisticon (Sweden) (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- The Lancet Regional Health - Europe
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1016/j.lanepe.2025.101485
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00